Eversept Partners’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$56.1M Buy
2,383,055
+484,251
+26% +$11.4M 5.16% 3
2025
Q1
$45.6M Buy
1,898,804
+298,789
+19% +$7.18M 4.63% 5
2024
Q4
$67.7M Sell
1,600,015
-450,142
-22% -$19M 6.01% 3
2024
Q3
$90.6M Buy
2,050,157
+6,943
+0.3% +$307K 6.21% 3
2024
Q2
$73.9M Buy
2,043,214
+219,433
+12% +$7.94M 5.06% 7
2024
Q1
$78.6M Sell
1,823,781
-91,049
-5% -$3.93M 5.25% 5
2023
Q4
$29.5M Buy
1,914,830
+436,341
+30% +$6.71M 2.59% 12
2023
Q3
$20.3M Sell
1,478,489
-262,462
-15% -$3.6M 1.72% 14
2023
Q2
$27.9M Sell
1,740,951
-47,578
-3% -$764K 2.34% 9
2023
Q1
$13.9M Buy
1,788,529
+1,377,221
+335% +$10.7M 0.97% 21
2022
Q4
$7.96M Buy
411,308
+255,179
+163% +$4.94M 0.7% 32
2022
Q3
$3.33M Buy
+156,129
New +$3.33M 0.29% 37